Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
American Journal of Preventive Cardiology|July 30, 2021
Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiationDiana N Vikulova, Ilia S Skorniakov, Brendon Bitoiu, et al.
The Canadian Journal of Cardiology|January 16, 2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and managementGeorge Thanassoulis, Sonia Anand, Benoit J Arsenault, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 10, 2009
Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosisLiam R Brunham, Roshni R Singaraja, MyNgan Duong, et al.
Nature Medicine|February 27, 2007
Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatmentLiam R Brunham, Janine K Kruit, Terry D Pape, et al.
Diabetes|February 9, 2012
Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired β-cell functionJanine K Kruit, Nadeeja Wijesekara, Clara Westwell-Roper, et al.
JIMD Reports|October 14, 2014
Clinical, Biochemical, and Molecular Characterization of Novel Mutations in ABCA1 in Families with Tangier DiseaseLiam R Brunham, Martin H Kang, Clara Van Karnebeek, et al.
The Canadian Journal of Cardiology|November 14, 2021
Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH RegistryGabrielle Roy, Patrick Couture, Jacques Genest, et al.
American Journal of Respiratory and Critical Care Medicine|October 16, 2018
Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in SepsisMark Trinder, Kelly R Genga, HyeJin Julia Kong, et al.
Atherosclerosis|February 5, 2026
Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotypeG B John Mancini, Arnold Ryomoto, Isabelle Ruel, et al.
The Journal of Clinical Investigation|April 21, 2005
Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-IJenelle M Timmins, Ji-Young Lee, Elena Boudyguina, et al.
Pageof 16